Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Platelets play role in Tylenol toxicity

April 30, 2020

Dopamine has epigenetic role in addiction

April 14, 2020

IXT-v100 vaccine decreases meth-taking and -seeking behaviors in vivo

April 8, 2020

New animal model more accurate for assessing nerve agent poisoning countermeasures

March 31, 2020

Heparan sulfate DAMPens acetaminophen toxicity

March 27, 2020

Paraoxonase 1 gene therapy offers long-term protection against lethal doses of nerve agents in mice

Feb. 13, 2020

Adial initiates pivotal phase III trial of AD-04 for alcohol use disorder

Feb. 7, 2020

FDA clears IND application for BXCL-501 for the treatment of opioid withdrawal symptoms

Feb. 6, 2020

Alkermes Pharma presents new naltrexone prodrugs for drug dependency

Feb. 5, 2020

Nr4a1 regulates gene transcription during cocaine abstinence: a potential target against addiction

Feb. 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...